|
|
|
Volumn 79, Issue 8, 2001, Pages 728-734
|
|
Initial lessons from public-private partnerships in drug and vaccine development
a,b
|
|
Author keywords
AIDS vaccines supply and distribution; Antimalarials supply and distribution; Antitubercular agents supply and distribution; Developing countries (source: MeSH); Drug industry; International agencies; Intersectoral cooperation; Investments; Organizations, Nonprofit organization and administration; Orphan drug production; Patents; Research; Social responsibility
|
|
Indexed keywords
DRUG;
VACCINE;
DRUG DEVELOPMENT;
PARTNERSHIP APPROACH;
PUBLIC-PRIVATE PARTNERSHIP;
VACCINATION;
COST BENEFIT ANALYSIS;
DRUG INDUSTRY;
DRUG RESEARCH;
EPIDEMIC;
HEALTH CARE FINANCING;
HEALTH CARE ORGANIZATION;
HEALTH CARE PLANNING;
HEALTH PROGRAM;
REVIEW;
ANTI-HIV AGENTS;
ANTIMALARIALS;
ANTITUBERCULAR AGENTS;
COMMUNICABLE DISEASES;
COOPERATIVE BEHAVIOR;
DEVELOPING COUNTRIES;
DRUG INDUSTRY;
FINANCING, ORGANIZED;
HUMANS;
INTERNATIONAL AGENCIES;
ORGANIZATIONAL AFFILIATION;
ORPHAN DRUG PRODUCTION;
PRIVATE SECTOR;
PUBLIC SECTOR;
RESEARCH;
RESEARCH SUPPORT;
SOCIAL RESPONSIBILITY;
|
|
EID: 0034888389
PISSN: 00429686
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (51)
|
|
References (14)
|
